News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Afluria Quadrivalent for Prevention of Infection from Influenza Virus

Afluria Quadrivalent is an inactivated influenza vaccine developed by Seqirus, which is developed to provide active immunisation against...

GLS-5700 DNA Vaccine for Prevention of Infection from Zika Virus

GLS-5700 is a synthetic vaccine being developed by Inovio Pharmaceuticals and GeneOne Life Sciences to prevent and treat infections...

August's top stories: Gradalis' Phase I breast cancer trial, Biothera and Merck conducted combination cancer immunotherapy trials

Gradalis dosed the first patient in its pilot Phase I trial of a combination of Vigil Engineered Autologous Tumour Cells (EATCs) and...

Adlyxin (lixisenatide) for the Treatment of Type 2 Diabetes

Adlyxin (lixisenatide) is an injectable solution developed by Sanofi for the treatment of type 2 diabetes in adults.


Latest Products & Services

Malvern Instruments
Zetasizer AT for DLS
Malvern's Zetasizer AT brings the industry leading Dynamic Light Scattering (DLS) technology of the Zetasizer Nano to the process development and manufacturing arena, enabling real...
See all products

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115